Jodie Hay

University of Glasgow — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

22h-index8.2kcitations70works12.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

FOXO transcription factor regulation(21), SARS-CoV-2 and COVID-19 Research(19), SARS-CoV-2 detection and testing(13), COVID-19 Clinical Research Studies(10), Chronic Lymphocytic Leukemia Research(9)

Publications69 total

USP7 inhibits FOXO1 activity downstream of the BCR in chronic lymphocytic leukaemia cells to enhance cell survival
2025Open Access
Implementation and adherence to regular asymptomatic testing in a COVID-19 vaccine trial
Vaccine·2024· 1 citedOpen Access
Bioengineered niches that recreate physiological extracellular matrix organisation to support long-term haematopoietic stem cells
Nature Communications·2024· 14 citedOpen Access
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Nature Communications·2024· 7 citedOpen Access
IL-27 maintains cytotoxic Ly6C+ γδ T cells that arise from immature precursors
The EMBO Journal·2024· 6 citedOpen Access
Implementation and Adherence to Regular Asymptomatic Testing in a COVID-19 Vaccine Trial
2024· 1 citedOpen Access
Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
Nature Communications·2024· 55 citedOpen Access
Author Reply to Peer Reviews of IL-27 maintains cytotoxic Ly6C+ gamma delta T cells that arise from immature precursors
2023
IL-27 maintains cytotoxic Ly6C <sup>+</sup> γδ T cells that arise from immature precursors
2023· 1 citedOpen Access
mTORC1-selective activation of translation elongation promotes disease progression in chronic lymphocytic leukemia
Leukemia·2023· 9 citedOpen Access
COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK
Scientific Reports·2023· 12 citedOpen Access
The discrete roles of individual FOXO transcription factor family members in B-cell malignancies
Frontiers in Immunology·2023· 30 citedOpen Access
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
Nature Communications·2023· 32 citedOpen Access
Suppl Table 1 from AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival
2023Open Access
Suppl Figure 3 from AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival
2023Open Access
Suppl Figure 7 from AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival
2023Open Access
Suppl Figure 1 from AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival
2023Open Access
Suppl Figure 1 from AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival
2023Open Access
Data from AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival
2023Open Access
Suppl Figure 4 from AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Koen B. Pouwels(18), Emma Pritchard(18), Karina-Doris Vihta(18), Philippa C. Matthews(17), Thomas House(17), Ruth Studley(17), A. Sarah Walker(17), Alison M. Michie(17), Nicole Stoesser(16), David W. Eyre(16), John I. Bell(16), John Newton(16), Ian Diamond(16), Tim Peto(15), Derrick W. Crook(14), Jeremy Farrar(13), Emma Rourke(13), Joel W. Jones(13), Julie V. Robotham(13), Paul Birrell(13)